author-photo

Gabriele Delconte

University of Milan

37

Papers

145

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Needle-based confocal endomicroscopy in the discrimination of mucinous from non-mucinous pancreatic cystic lesions

2021 World Journal of Gastrointestinal Endoscopy
Show All
- Source
- Cite
- Save
Citations (0)
OC.01.6 A NEW FULLY COVERED SELF-EXPANDABLE METAL FOR ENDOSCOPIC TREATMENT OF POST-OLT BILIARY ANASTOMOTIC STRICTURES (AD INTERIM EVALUATION) (BASALT STUDY)

2020 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
T03.02.5 ACCURACY OF NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY (NCLE) IN THE DISCRIMINATION OF MUCINOUS VS NON MUCINOUS PANCREATIC CYSTIC LESIONS: AN ITALIAN MULTICENTER PROSPECTIVE STUDY

2020 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)
Endosonographic evaluation of the mediastinum through the i-gel O2 supraglottic airway device:

2019 Tumori
Show All
- Source
- Cite
- Save
Citations (0)
Plasma miRNA‐based Signatures in CRC Screening Programs

2019 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (17)
CLINICAL PERFORMANCE OF NEW THREE POINTS 19 G ENDOSCOPIC ULTRASOUND CORE NEEDLE FOR THE HISTOLOGICAL DIAGNOSIS OF MESENCHYMAL TUMORS

2019
Show All
- Source
- Cite
- Save
Citations (0)
Tu1354 CLINICAL PERFORMANCE OF NEW THREE POINTS 19 G ENDOSCOPIC ULTRASOUND CORE NEEDLE FOR THE HISTOLOGICAL DIAGNOSIS OF MESENCHYMAL TUMORS

2019 Gastrointestinal Endoscopy
Show All
- Source
- Cite
- Save
Citations (0)
Sa1725 – Leopard Study - Italian Multicenter Prospective Study of Pancreatic Cystic Lesions with Confocal Endomicroscopy: Feasibility and Safety Evaluation

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection

2019 Ejso
Show All
- Source
- Cite
- Save
Citations (8)
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions

2017 Oncology
Show All
- Source
- Cite
- Save
Citations (5)